| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |